PHILIP BRITTON: Open Payments
NPI 1780691436 · BOCA RATON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,097 in 83 payments from 20 companies in 2025. Trend: 2023 $1,317 · 2024 $3,460 · 2025 $2,097
Food & beverage: $2,097
| Company | Payments | Amount |
|---|---|---|
| LNHC, Inc | 6 | $328 |
| GENZYME CORPORATION | 9 | $327 |
| ABBVIE INC. | 12 | $263 |
| Incyte Corporation | 14 | $262 |
| Janssen Biotech, Inc. | 9 | $192 |
| Regeneron Healthcare Solutions, Inc. | 4 | $102 |
| Arcutis Biotherapeutics, Inc. | 4 | $79 |
| UCB, Inc. | 2 | $78 |
| LEO Pharma Inc. | 3 | $64 |
| Organon LLC | 5 | $57 |
Products named: DUPIXENT, ZELSUVMI, OPZELURA, SKYRIZI, TREMFYA, Zoryve, Bimzelx, SOFDRA.
Industry payments across FL — which companies pay providers there.
